Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
Authors
Keywords
-
Journal
EMBO Molecular Medicine
Volume -, Issue -, Pages n/a-n/a
Publisher
EMBO
Online
2014-01-08
DOI
10.1002/emmm.201303543
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immuno- and Constitutive Proteasomes Do Not Differ in Their Abilities to Degrade Ubiquitinated Proteins
- (2013) James A. Nathan et al. CELL
- Immuno- and Constitutive Proteasome Crystal Structures Reveal Differences in Substrate and Inhibitor Specificity
- (2012) Eva M. Huber et al. CELL
- The immunoproteasome in antigen processing and other immunological functions
- (2012) Michael Basler et al. CURRENT OPINION IN IMMUNOLOGY
- Immunoproteasome Subunit LMP7 Deficiency and Inhibition Suppresses Th1 and Th17 but Enhances Regulatory T Cell Differentiation
- (2012) K. W. Kalim et al. JOURNAL OF IMMUNOLOGY
- A Critical Role for the Inducible Proteasomal Subunits LMP7 and MECL1 in Cytokine Production by Activated Murine Splenocytes
- (2012) Cheryl E. Rockwell et al. PHARMACOLOGY
- CC chemokine receptor 4 is required for experimental autoimmune encephalomyelitis by regulating GM-CSF and IL-23 production in dendritic cells
- (2012) K. Poppensieker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody-secreting cells
- (2011) H. Travis Ichikawa et al. ARTHRITIS AND RHEUMATISM
- TH17 cytokines in autoimmune neuro-inflammation
- (2011) Burkhard Becher et al. CURRENT OPINION IN IMMUNOLOGY
- Cytokines and effector T cell subsets causing autoimmune CNS disease
- (2011) Franziska Petermann et al. FEBS LETTERS
- The Antiviral Immune Response in Mice Devoid of Immunoproteasome Activity
- (2011) M. Basler et al. JOURNAL OF IMMUNOLOGY
- Mice completely lacking immunoproteasomes show major changes in antigen presentation
- (2011) Eleanor Z Kincaid et al. NATURE IMMUNOLOGY
- RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation
- (2011) Laura Codarri et al. NATURE IMMUNOLOGY
- The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF
- (2011) Mohamed El-Behi et al. NATURE IMMUNOLOGY
- Mouse models for multiple sclerosis: Historical facts and future implications
- (2010) Andrew L. Croxford et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- PR-924, a selective inhibitor of the immunoproteasome subunit LMP-7, blocks multiple myeloma cell growth both in vitro and in vivo
- (2010) Ajita V. Singh et al. BRITISH JOURNAL OF HAEMATOLOGY
- Immunoproteasomes Preserve Protein Homeostasis upon Interferon-Induced Oxidative Stress
- (2010) Ulrike Seifert et al. CELL
- Immunoproteasomes are essential for survival and expansion of T cells in virus-infected mice
- (2010) Jacqueline Moebius et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis
- (2010) N. Schmidt et al. GUT
- Unexpected Role for the Immunoproteasome Subunit LMP2 in Antiviral Humoral and Innate Immune Responses
- (2010) S. E. Hensley et al. JOURNAL OF IMMUNOLOGY
- Prevention of Experimental Colitis by a Selective Inhibitor of the Immunoproteasome
- (2010) M. Basler et al. JOURNAL OF IMMUNOLOGY
- The Proteasome Inhibitor Bortezomib Enhances the Susceptibility to Viral Infection
- (2009) M. Basler et al. JOURNAL OF IMMUNOLOGY
- A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis
- (2009) Tony Muchamuel et al. NATURE MEDICINE
- Targeted inhibition of the immunoproteasome is a potent strategy against models of multiple myeloma that overcomes resistance to conventional drugs and nonspecific proteasome inhibitors
- (2008) Deborah J. Kuhn et al. BLOOD
- Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation
- (2008) Nicolas Fissolo et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis
- (2008) Kirsten Neubert et al. NATURE MEDICINE
- Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis
- (2007) John S. Tzartos et al. AMERICAN JOURNAL OF PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now